Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.
about
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primatesCurrent ebola vaccinesDurability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primatesMucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responsesA Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary ReportEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentTransmission of Ebola virus from pigs to non-human primatesEbola haemorrhagic feverClinical development of Ebola vaccinesAddressing Therapeutic Options for Ebola Virus Infection in Current and Future OutbreaksEbola virus vaccines: an overview of current approachesStandardization of the filovirus plaque assay for use in preclinical studiesMouse models for filovirus infectionsEfficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the BrainRescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNASeeking Clearer Recommendations for Hand Hygiene in Communities Facing Ebola: A Randomized Trial Investigating the Impact of Six Handwashing Methods on Skin Irritation and DermatitisABSL-4 aerobiology biosafety and technology at the NIH/NIAID integrated research facility at Fort DetrickAvian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetEbola and Marburg virus vaccines.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola VirusA viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses."Filoviruses": a real pandemic threat?Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge.Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirusA characterization of aerosolized Sudan virus infection in African green monkeys, cynomolgus macaques, and rhesus macaquesExpression of an immunogenic Ebola immune complex in Nicotiana benthamiana.Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization.Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose.Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus.Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primatesSingle-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus.Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.Next-generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein (VSVΔG/EBOVgp).
P2860
Q21090120-AAB0C1FF-E998-48A0-82E7-0214D7D2ADC7Q21534720-1F5EAA15-3723-4F6E-B018-25A786B86373Q21559476-B9E864CD-5A76-417D-9274-D01C592CDBE7Q21562420-E4A279E8-828B-435A-A756-7329F73B87B1Q24289295-AC8C697F-A0C0-4932-BA4F-22DF4219B6FFQ24597625-7E39AD42-A7AB-4327-BC31-2E514BECDD4AQ24612028-3D0948E2-CE91-4C70-8E85-FA379D3E7688Q24629338-36A08047-82CA-4EE7-8C27-7DDA19947025Q26775792-253E2751-D29B-47D5-80A4-484911E0F605Q26801423-5C06ED87-D48E-48A4-974F-E76E3AF7DF66Q26999232-AA6DBD96-3EB3-4785-BDCE-D57C973830B4Q27000207-65DF44FD-BAD7-4FF1-845E-32762A27100BQ27011569-8AA55B25-AE40-4EB1-BF6A-F17A7A7FD381Q28051937-99AFF1A8-9E5F-4391-AD88-0C0ABD9E0DEDQ28223031-7F4941B9-4CF1-4328-A745-3064C556085CQ28396399-BE5E17AA-5067-49BF-8AC1-1CC85C78BD56Q29248412-E33C97C1-D692-4B3C-B986-B2AEA4CF6FADQ30217454-52ADE99A-D8AC-49F6-AE03-61015B2F973AQ30227194-28353764-5153-4480-A018-F778AF7E1A9EQ30234637-D7C34C33-A242-48CD-9DD5-5FA069840E7FQ30235073-AA014835-2BE1-4EE5-8D3A-7EBE3BC666DDQ30370147-9124C8C4-8A73-4C66-AE7C-249AF1D9F0FCQ30382097-8050080C-CF9E-4835-A086-6FF5A9E904DCQ30384090-86B1EE5C-6193-4AAE-9F36-AC3B054E48EAQ30385999-48304C18-842A-46C6-A1A0-485897549D9DQ30724121-921855B4-7E11-4D9C-A9F7-7415E789A424Q33404642-3509418F-5E6E-4BF4-80DA-60A1319EAF8FQ33619065-7CE7B885-F949-4B20-B01A-827A9B7E6FFFQ33715773-19523A88-BFFC-4E48-9D93-2C1D1934700BQ33768646-5212BB3B-B25D-4FEC-9449-570BFD6ED2DCQ33818337-0D716016-60FB-4A83-862B-035324C4F9A7Q33964081-F39A3D03-BE93-4C38-8E3D-A777E80D8C10Q33981963-605E5D02-95DA-44DE-81AF-201751D993D7Q34040052-9734C249-F0FC-43FC-B36F-7E32A54B2370Q34463780-D2CCE7A1-54C2-47C9-BA5F-E04DB29D6C39Q34468847-911BA5D0-4079-4FEC-8AB5-F2AF8FF031AAQ34606818-907FE8D0-8266-42FF-84E0-479B5CE336F3Q34742846-B0BB6127-488A-48F5-855D-4967D3156E3BQ34761889-6AB9BD3D-4068-469B-A272-9C3BB8CD417CQ35122795-F5D58207-7F23-4748-AAE2-C69E8CA06DD9
P2860
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Vesicular stomatitis virus-bas ...... ith Ebola and Marburg viruses.
@ast
Vesicular stomatitis virus-bas ...... ith Ebola and Marburg viruses.
@en
Vesicular stomatitis virus-bas ...... ith Ebola and Marburg viruses.
@nl
type
label
Vesicular stomatitis virus-bas ...... ith Ebola and Marburg viruses.
@ast
Vesicular stomatitis virus-bas ...... ith Ebola and Marburg viruses.
@en
Vesicular stomatitis virus-bas ...... ith Ebola and Marburg viruses.
@nl
prefLabel
Vesicular stomatitis virus-bas ...... ith Ebola and Marburg viruses.
@ast
Vesicular stomatitis virus-bas ...... ith Ebola and Marburg viruses.
@en
Vesicular stomatitis virus-bas ...... ith Ebola and Marburg viruses.
@nl
P2093
P2860
P50
P921
P1433
P1476
Vesicular stomatitis virus-bas ...... ith Ebola and Marburg viruses.
@en
P2093
Elizabeth A Fritz
Joan B Geisbert
Kathleen M Daddario-Dicaprio
Steven M Jones
P2860
P304
P356
10.1016/J.VACCINE.2008.09.082
P407
P50
P577
2008-10-18T00:00:00Z